Results

1–10 of 82 results for Genetics

Multicenter Randomized Sham-Controlled Double-Masked Phase 2b Clinical Trial of Multi-Characteristic Opsin in Patients With Advanced Retinitis Pigmentosa
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2022
One Year Follow-Up in a Phase ½ Clinical Trial of a Gene Modifier Therapy (OCU400) for the Treatment of Retinitis Pigmentosa
Benjamin Bakall, MD, PhD
Updates from the Field
2024
BVA Analysis of Low- or High-Dose MCO-010 Optogenetics Therapy for Retinitis Pigmentosa: First Time 100-Week TOPLINE Results From a Phase 2b/3 Clinical trial (RESTORE)
Michael A. Singer, MD
Updates from the Field
2024
Sickle Cell Retinopathy (Proliferative) - Color
Ricardo Leitão Guerra
Retina Image Bank: Images of the Week
2023
Subretinal Gene Therapy Drug AGTC-501 for X-Linked Retinitis Pigmentosa: Phase 2 Randomized Controlled Masked Multicenter Clinical Trial (Skyline) Interim Safety Results
On Demand Cases, Courses, and Papers
2022
Safety and Efficacy of Intravitreal Optogenetic Gene Therapy for Advanced Retinitis Pigmentosa
Sai H Chavala, MD
On Demand Cases, Courses, and Papers
2021
Recognizable Patterns of Submacular Fibrosis in the Enhanced S-Cone Syndrome
Sawsan R Nowilaty, MD, FASRS
Annual Meeting Talks
2021
Gene Expression Profile and Local Tumor Recurrence of Irradiated Uveal Melanomas
Basil K Williams, MD
Updates from the Field
2022
Impact of PRAME Status on Gene Expression Profile to Predict Metastasis in Uveal Melanoma: Interim Analysis of the Collaborative Ocular Oncology Group Study Number 2 (COOG2)
Prithvi Mruthyunjaya, MD, MHS
Updates from the Field
2022
Familial Retinal Arterial Macroaneurysms With Supravalvular Pulmonic Stenosis: A Syndrome With Life Threatening Potential You Should Not Miss
Sawsan R Nowilaty, MD, FASRS
On Demand Cases, Courses, and Papers
2020